Alicia Secor
Alicia most recently served as president and chief executive officer at Juniper Pharmaceuticals, Inc., a diversified public healthcare company where she led the successful turnaround strategy for the company resulting in a sale to Catalent, Inc. in August 2018.
Contact
- Email: ******@atalantatx.com
Companies
Company
Roles
Atalanta Therapeutics
Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
CEO
Orchard Therapeutics
Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.
Board Member
G1 Therapeutics
A company developing small molecule therapies to treat cancer
Board Member